Research
Hormonal
Weight-loss medications, especially incretin mimetics, are effective for short- and long-term treatment of obesity-related hypertension.
Practitioners may consider prescribing incretin mimetics for effective management of obesity-related hypertension.
StrongSupportsmedium confidence
Weight-loss medications, especially incretin mimetics, are effective for short- and long-term treatment.
Why this rating
The claim is based on established research regarding the effectiveness of these medications.
Source
Obesity-related hypertension
Irina Benenson et al. · The Nurse Practitioner · 2023
DOI 10.1097/01.npr.0000000000000055
reviewCited 2×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →